MedTrace Logo

Daily-life Brain Control Of A Hand Exoskeleton After Cervical Spinal Cord Injury

NCT02336321 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2015-05-14

No results posted yet for this study

Summary

In this study, 6 volunteer participants with chronic spinal cord injury will be invited to use an autonomous hand exoskeleton device controlled by a brain/neural-computer interaction (BNCI) system fusing electroencephalography (EEG) and electrooculography (EOG) to detect the intention of the user to grasp objects of daily life. The BNCI system consists of a lightweight hand exoskeleton connected to portable motors, rechargeable batteries and a computerized control system integrated into a wheelchair. Before, during and after use of the BNCI system the volunteers will perform standardized assessments and complete questionnaires to assess the functional and psychological effects of the exoskeleton. Functional outcomes primarily focus on motor function in performing daily life actions while psychological outcomes primarily focus on safety, reliability as well as predisposition and perceptions of disability.

Conditions

  • Spinal Cord Injury

Interventions

DEVICE

BNCI controlled hand exoskeleton

The BNCI system fuses and translates bio-signals related to user intention into control signals of an assistive device performing grasping motions

Sponsors & Collaborators

  • Institut Guttmann

    collaborator OTHER

  • Scuola Superiore Sant'Anna di Studi Universitari e di Perfezionamento

    collaborator OTHER

  • University Hospital Tuebingen

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-10-31
Completion
2015-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02336321 on ClinicalTrials.gov